These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Influence of the angiotensin II receptor antagonist losartan on diuretic-induced metabolic effects in elderly hypertensive patients: comparison with a calcium channel blocker. Ohnishi K; Kohno M; Yukiiri K; Masugata H; Wada Y; Takagi Y; Ohmori K Int J Clin Pharmacol Ther; 2001 Oct; 39(10):417-22. PubMed ID: 11680666 [TBL] [Abstract][Full Text] [Related]
29. The plasma renin test reveals the contribution of body sodium-volume content (V) and renin-angiotensin (R) vasoconstriction to long-term blood pressure. Laragh JH; Sealey JE Am J Hypertens; 2011 Nov; 24(11):1164-80. PubMed ID: 21938070 [TBL] [Abstract][Full Text] [Related]
30. Trends in antihypertensive treatment--lessons from the National Acute Stroke Israeli (NASIS) registry. Koifman E; Tanne D; Molshatzki N; Leibowitz A; Grossman E Blood Press; 2014 Oct; 23(5):262-9. PubMed ID: 24483945 [TBL] [Abstract][Full Text] [Related]
31. Combination therapies for hypertension - why we need to look beyond RAS blockers. Gorostidi M; de la Sierra A Expert Rev Clin Pharmacol; 2018 Sep; 11(9):841-853. PubMed ID: 30092149 [TBL] [Abstract][Full Text] [Related]
32. [Salt sensitive blood pressure and the renin-angiotensin system in hypertension]. Krekels MM; de Leeuw PW Ned Tijdschr Geneeskd; 1997 Nov; 141(47):2285-9. PubMed ID: 9550812 [TBL] [Abstract][Full Text] [Related]
33. Management of hypertension with fixed-dose triple-combination treatments. Epstein BJ; Shah NK; Borja-Hart NL Ther Adv Cardiovasc Dis; 2013 Oct; 7(5):246-59. PubMed ID: 23945906 [TBL] [Abstract][Full Text] [Related]
34. Current status of antihypertensive prescription and associated blood pressure control in Japan. Mori H; Ukai H; Yamamoto H; Saitou S; Hirao K; Yamauchi M; Umemura S Hypertens Res; 2006 Mar; 29(3):143-51. PubMed ID: 16755149 [TBL] [Abstract][Full Text] [Related]
35. Blood pressure lowering efficacy of beta-blockers as second-line therapy for primary hypertension. Chen JM; Heran BS; Perez MI; Wright JM Cochrane Database Syst Rev; 2010 Jan; (1):CD007185. PubMed ID: 20091622 [TBL] [Abstract][Full Text] [Related]
36. [Correlations between blood pressure, blood volume and plasma renin during therapy with diuretics in essential hypertension. Comparison between the mineralocorticoid antagonist spironolactone and the "loop" diuretic mefruside]. Beretta-Piccoli C; Weidmann P; de Châtel R; Hirsch D; Reubi FC Schweiz Med Wochenschr; 1977 Jan; 107(4):104-15. PubMed ID: 834983 [TBL] [Abstract][Full Text] [Related]
37. Association between cardiovascular outcomes and antihypertensive drug treatment in older women. Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916 [TBL] [Abstract][Full Text] [Related]
38. High-dose monotherapy vs low-dose combination therapy of calcium channel blockers and angiotensin receptor blockers in mild to moderate hypertension. Andreadis EA; Tsourous GI; Marakomichelakis GE; Katsanou PM; Fotia ME; Vassilopoulos CV; Diamantopoulos EJ J Hum Hypertens; 2005 Jun; 19(6):491-6. PubMed ID: 15759025 [TBL] [Abstract][Full Text] [Related]
39. [Relationship of the renin-angiotensin-aldosterone system with auricular natriuretic factor in its response to the action of thiazide diuretics and to nifedipine, a sustained-release calcium antagonist]. Ocón J; Mora-Macià J; Castellet R; del Río G Med Clin (Barc); 1994 Jan; 102(2):41-5. PubMed ID: 8133694 [TBL] [Abstract][Full Text] [Related]
40. Exploring the optimal combination therapy in hypertensive patients with diabetes mellitus. Reboldi G; Gentile G; Angeli F; Verdecchia P Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1349-61. PubMed ID: 19900018 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]